KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Liabilities and Shareholders Equity: 2010-2014

Historic Liabilities and Shareholders Equity for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2014 value amounting to $136.9 million.

  • Biocryst Pharmaceuticals' Liabilities and Shareholders Equity rose 1.34% to $139.0 million in Q3 2015 from the same period last year, while for Sep 2015 it was $555.9 million, marking a year-over-year increase of 49.69%. This contributed to the annual value of $136.9 million for FY2014, which is 180.10% up from last year.
  • According to the latest figures from FY2014, Biocryst Pharmaceuticals' Liabilities and Shareholders Equity is $136.9 million, which was up 180.10% from $48.9 million recorded in FY2013.
  • In the past 5 years, Biocryst Pharmaceuticals' Liabilities and Shareholders Equity ranged from a high of $136.9 million in FY2014 and a low of $48.9 million during FY2013.
  • In the last 3 years, Biocryst Pharmaceuticals' Liabilities and Shareholders Equity had a median value of $57.4 million in 2012 and averaged $81.1 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first plummeted by 30.13% in 2012, then soared by 180.10% in 2014.
  • Yearly analysis of 5 years shows Biocryst Pharmaceuticals' Liabilities and Shareholders Equity stood at $109.4 million in 2010, then dropped by 24.89% to $82.2 million in 2011, then plummeted by 30.13% to $57.4 million in 2012, then declined by 14.93% to $48.9 million in 2013, then soared by 180.10% to $136.9 million in 2014.